Horizon Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Horizon Investments's JAZZ Position: Q2 2026 in Review
Horizon Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 286% in Q2 2026, buying an estimated $2.97M and bringing the position to 18,295 shares worth $4.41M. The position accounts for 0.05% of the portfolio, ranked #316.
Horizon Investments first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.88M in Q2 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Horizon Investments held 18,295 shares of Jazz Pharmaceuticals worth $4.41M as of Q2 2026.
- Horizon Investments bought 13,555 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.97M.
- Jazz Pharmaceuticals made up 0.05% of Horizon Investments's portfolio in Q2 2026, its #316 holding.
- Horizon Investments first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
- Horizon Investments's Jazz Pharmaceuticals position peaked at $8.88M in Q2 2025.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.